Paper · 6935293

Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Ozato K and 1 other. J Immunol, 1981. Cited by 799 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. Papers, record 6935293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6935293

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.; PubMed
Journal: J Immunol; PubMed
Year: 1981; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/6935293/; PubMed
The journal: https://conductscience.org/library/journal-index/2985117R; PubMed
Citations, by iCite: 799; iCite
Relative citation ratio, by iCite: 15.4; iCite
Revised in PubMed: 2020-12-22; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Ozato K	K
2	Sachs DH	D H

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
H-2 Antigens	Major topic
Haploidy	Major topic
Hybrid Cells	Major topic
Major Histocompatibility Complex	Major topic
Animals
Antibodies
Antibody Specificity
Antigen-Antibody Reactions
Cell Line
Clone Cells
Cross Reactions
Cytotoxicity, Immunologic
Female
Histocompatibility Antigens Class II
Male
Mice
Mice, Inbred C3H

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by236

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 799 citations.

PMID	Title	Journal	Year	In Papers	Source
35,647,522	Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface.	Curr Res Immunol	2022	https://conductscience.org/library/papers/35647522	PubMed
34,995,990	A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability.	Mol Immunol	2022	https://conductscience.org/library/papers/34995990	PubMed
30,180,933	A two-hybrid antibody micropattern assay reveals specific in cis interactions of MHC I heavy chains at the cell surface.	Elife	2018	https://conductscience.org/library/papers/30180933	PubMed
29,100,268	ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis.	Oncotarget	2017	https://conductscience.org/library/papers/29100268	PubMed
28,592,828	A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle.	Sci Rep	2017	https://conductscience.org/library/papers/28592828	PubMed
26,405,573	Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models.	Oncoimmunology	2015	https://conductscience.org/library/papers/26405573	PubMed
26,389,800	A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents.	PLoS One	2015	https://conductscience.org/library/papers/26389800	PubMed
25,959,091	Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.	Immunology	2015	https://conductscience.org/library/papers/25959091	PubMed
22,358,883	Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.	Cytotechnology	1997	https://conductscience.org/library/papers/22358883	PubMed
22,025,304	MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice.	J Exp Med	2011	https://conductscience.org/library/papers/22025304	PubMed

1 to 10 of 236

See all 236 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6935293

GET https://conductscience.org/api/papers/v1/6935293/cited_by?page=2

API reference For AI assistants